Adaptin Bio, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-5.2M | $-3.1M | $-85.6K |
| Depreciation & Amortization | — | — | — |
| Depreciation | — | — | — |
| Amortization | — | — | — |
| Stock-Based Compensation | $496.9K | — | — |
| Net Cash from Operating Activities | $-4.8M | $-649.3K | $-81.0K |
| Investing Activities | |||
| Capital Expenditures | — | — | — |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | — | — | — |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $5.2M | $678.6K | $80.9K |
| Net Change in Cash | — | — | — |
| Free Cash Flow | — | — | — |